Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abetalipoproteinemia
Acanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
Abetalipoproteinemia
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic.
Anemia, Sideroblastic
[Genetics of hereditary iron overload]
Ataxia
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Azoospermia
Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia.
Azoospermia
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
Azoospermia
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Azoospermia
Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model.
Basal Ganglia Diseases
Neurodegeneration with brain iron accumulation.
Brain Diseases
Pantothenate kinase-associated neurodegeneration in two Chinese children: identification of a novel PANK2 gene mutation.
Brain Diseases
Status dystonicus: management and prevention in children at high risk.
Carcinoma, Hepatocellular
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation.
Cataract
A novel mutation of PANK4 causes autosomal dominant congenital posterior cataract.
Cerebellar Ataxia
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Chorea
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Deglutition Disorders
Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia.
Dementia
Pantothenate kinase 2 deficiency: A neurodegeneration with brain iron accumulation.
Diabetes Mellitus, Type 2
[Screening susceptibility genes of type 2 diabetes in Chinese population by single nucleotide polymorphism analysis]
Dysarthria
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Dysarthria
Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Dysarthria
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Dyskinesias
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Dyskinesias
Psychiatric symptoms in an adolescent reveal a novel compound heterozygous mutation of the PANK2 gene in the atypical PKAN syndrome.
Dyskinesias
[Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)]
Dystonia
A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia.
Dystonia
A novel PANK2 gene mutation with sudden-onset dystonia.
Dystonia
Characterization of the human PANK2 promoter.
Dystonia
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Dystonia
Focal hand dystonia in a patient with PANK2 mutation.
Dystonia
Low prevalence of PANK2 mutations in Brazilian patients with early onset generalised dystonia and basal ganglia abnormalities on MRI.
Dystonia
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Dystonia
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Dystonia
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Dystonia
Pyruvate dehydrogenase E2 deficiency: A potentially treatable cause of episodic dystonia.
Dystonia
Rare causes of dystonia parkinsonism.
Dystonia
Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions.
Dystonia
Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
Dystonia
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)]
Dystonic Disorders
Status dystonicus: management and prevention in children at high risk.
Essential Tremor
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Friedreich Ataxia
Neurodegeneration with brain iron accumulation - Clinical syndromes and neuroimaging.
Friedreich Ataxia
[Genetics of hereditary iron overload]
Genetic Diseases, Inborn
Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis.
Genetic Diseases, Inborn
Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
Genetic Diseases, Inborn
Iron toxicity as a potential factor in AMD.
Genetic Diseases, Inborn
Panthotenate Kinase-Associated Neurodegeneration Has a Founder Mutation (c.215_216insa) in Indian Agrawal Patients.
Genetic Diseases, Inborn
[Genetics of hereditary iron overload]
Glioma
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation.
Hepatoblastoma
PPARalpha controls the intracellular coenzyme A concentration via regulation of PANK1alpha gene expression.
Hepatolenticular Degeneration
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Hepatolenticular Degeneration
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.
Hepatolenticular Degeneration
Rare causes of dystonia parkinsonism.
Hyperglycemia
Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.
Hypertriglyceridemia
Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state.
Hypoglycemia
Germline Deletion of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism.
Hypolipoproteinemias
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic.
Infections
Activation of Anopheles stephensi Pantothenate Kinase and Coenzyme A Biosynthesis Reduces Infection with Diverse Plasmodium Species in the Mosquito Host.
Infections
Pantothenic acid metabolism during avian malaria infection: pantothenate kinase activity in duck erythrocytes and in Plasmodium lophurae.
Infertility, Male
Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model.
Influenza, Human
Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.
Insulin Resistance
Pank1 deletion in leptin-deficient mice reduces hyperglycaemia and hyperinsulinaemia and modifies global metabolism without affecting insulin resistance.
Intellectual Disability
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Iron Overload
Iron toxicity as a potential factor in AMD.
Iron Overload
[Genetics of hereditary iron overload]
Iron Overload
[Hemochromatosis: one form of iron-overload diseases].
Learning Disabilities
Pyruvate dehydrogenase E2 deficiency: A potentially treatable cause of episodic dystonia.
Lipid Metabolism Disorders
[Clinical characteristics and molecular pathogenesis of pantothenate kinase-associated neurodegenerative disease].
Macular Degeneration
Iron toxicity as a potential factor in AMD.
Malaria
A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites.
Malaria
Feedback inhibition of pantothenate kinase regulates pantothenol uptake by the malaria parasite.
Malaria
Genetic Characterization of Plasmodium Putative Pantothenate Kinase Genes Reveals Their Essential Role in Malaria Parasite Transmission to the Mosquito.
Malaria, Avian
Pantothenic acid metabolism during avian malaria infection: pantothenate kinase activity in duck erythrocytes and in Plasmodium lophurae.
Malaria, Avian
Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum.
Metabolic Diseases
Functional connectivity of the motor system in dystonia due to PKAN.
Metabolic Diseases
P53/PANK1/miR-107 signalling pathway spans the gap between metabolic reprogramming and insulin resistance induced by high-fat diet.
Movement Disorders
7-Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers.
Movement Disorders
A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration.
Movement Disorders
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
Movement Disorders
Hereditary parkinsonism: Parkinson disease look-alikes-An algorithm for clinicians to "PARK" genes and beyond.
Movement Disorders
Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients.
Movement Disorders
Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.
Movement Disorders
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Movement Disorders
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation.
Movement Disorders
Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
Movement Disorders
The "eye of the tiger" sign in pure akinesia with gait freezing.
Movement Disorders
[Hemochromatosis: one form of iron-overload diseases].
Multiple Sclerosis
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Muscle Rigidity
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Neoplasms
Pleiotropic functions of miR107 in cancer networks.
Neoplasms
Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer.
Nervous System Diseases
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
Neuroacanthocytosis
Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis.
Neuroaxonal Dystrophies
Iron Accumulation in Syndromes of Neurodegeneration with Brain Iron Accumulation 1 and 2 - causative or consequential?
Neuroaxonal Dystrophies
Neurodegeneration with brain iron accumulation - Clinical syndromes and neuroimaging.
Neuroaxonal Dystrophies
Neurodegeneration with brain iron accumulation.
Neuroaxonal Dystrophies
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.
Neuroblastoma
Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
Neuroblastoma
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation.
Neurodegenerative Diseases
A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration.
Neurodegenerative Diseases
A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.
Neurodegenerative Diseases
A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir - India.
Neurodegenerative Diseases
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine.
Neurodegenerative Diseases
Coenzyme A: back in action.
Neurodegenerative Diseases
Cofilin/Twinstar phosphorylation levels increase in response to impaired coenzyme a metabolism.
Neurodegenerative Diseases
Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.
Neurodegenerative Diseases
Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish.
Neurodegenerative Diseases
Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Neurodegenerative Diseases
Hereditary causes of disturbed iron homeostasis in the central nervous system.
Neurodegenerative Diseases
Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Neurodegenerative Diseases
Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration.
Neurodegenerative Diseases
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.
Neurodegenerative Diseases
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Neurodegenerative Diseases
Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.
Neurodegenerative Diseases
PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes.
Neurodegenerative Diseases
Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration.
Neurodegenerative Diseases
Rare causes of hereditary iron overload.
Neurodegenerative Diseases
Status dystonicus: management and prevention in children at high risk.
Neurologic Manifestations
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.
pantothenate kinase deficiency
Acetyl-4'-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency.
pantothenate kinase deficiency
Localization and regulation of mouse pantothenate kinase 2.
pantothenate kinase deficiency
Pank1 deletion in leptin-deficient mice reduces hyperglycaemia and hyperinsulinaemia and modifies global metabolism without affecting insulin resistance.
pantothenate kinase deficiency
Pantothenate kinase 2 deficiency: A neurodegeneration with brain iron accumulation.
pantothenate kinase deficiency
Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties.
pantothenate kinase deficiency
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)]
pantothenate kinase deficiency
[Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)]
Pantothenate Kinase-Associated Neurodegeneration
"Eye of tiger sign" mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN).
Pantothenate Kinase-Associated Neurodegeneration
'Eye-of-the-Tiger' Sign and Classic Pantothenate Kinase Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect.
Pantothenate Kinase-Associated Neurodegeneration
A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A Novel Nonsense Mutation in PANK2 Gene in Two Patients with Pantothenate Kinase-Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A novel PANK2 mutation in a 12-year-old Chinese boy with pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.
Pantothenate Kinase-Associated Neurodegeneration
A pantothenate kinase-deficient mouse model reveals a gene expression program associated with brain coenzyme a reduction.
Pantothenate Kinase-Associated Neurodegeneration
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir - India.
Pantothenate Kinase-Associated Neurodegeneration
Abnormal Vasculature Development in Zebrafish Embryos with Reduced Expression of Pantothenate Kinase 2 Gene.
Pantothenate Kinase-Associated Neurodegeneration
Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.
Pantothenate Kinase-Associated Neurodegeneration
Acanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
Pantothenate Kinase-Associated Neurodegeneration
Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis.
Pantothenate Kinase-Associated Neurodegeneration
An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.
Pantothenate Kinase-Associated Neurodegeneration
Anticholinergic-responsive gait freezing in a patient with pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Atypical Hallervorden-Spatz disease with preserved cognition and obtrusive obsessions and compulsions.
Pantothenate Kinase-Associated Neurodegeneration
Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature.
Pantothenate Kinase-Associated Neurodegeneration
Basal ganglia calcification and novel compound heterozygous mutations in the PANK2 gene in a Chinese boy with classic Pantothenate kinase-associated neurodegeneration: A case report.
Pantothenate Kinase-Associated Neurodegeneration
Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN.
Pantothenate Kinase-Associated Neurodegeneration
Characterization of the human PANK2 promoter.
Pantothenate Kinase-Associated Neurodegeneration
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).
Pantothenate Kinase-Associated Neurodegeneration
Clinical and genetic delineation of neurodegeneration with brain iron accumulation.
Pantothenate Kinase-Associated Neurodegeneration
Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.
Pantothenate Kinase-Associated Neurodegeneration
CLINICAL EFFECT OF A MUTATION (p.Glu322Asp, c.966 G>T) IN PANK2 GENE IN A FAMILY WITH ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION.
Pantothenate Kinase-Associated Neurodegeneration
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Conversion disorder as initial diagnosis in pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
Pantothenate Kinase-Associated Neurodegeneration
Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system.
Pantothenate Kinase-Associated Neurodegeneration
Deep brain stimulation as treatment for dystonic storm in pantothenate kinase-associated neurodegeneration syndrome: case report of a patient with homozygous C.628 2 T?>?G mutation of the PANK2 gene.
Pantothenate Kinase-Associated Neurodegeneration
Deep Brain Stimulation in Pantothenate Kinase Associated Neurodegeneration: challenges for the future.
Pantothenate Kinase-Associated Neurodegeneration
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Pantothenate Kinase-Associated Neurodegeneration
Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Pantothenate Kinase-Associated Neurodegeneration
Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN).
Pantothenate Kinase-Associated Neurodegeneration
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds.
Pantothenate Kinase-Associated Neurodegeneration
Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Eye-of-the-tiger Sign in Neurodegeneration with Brain Iron Accumulation.
Pantothenate Kinase-Associated Neurodegeneration
First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
Pantothenate Kinase-Associated Neurodegeneration
First successful trial of preimplantation genetic diagnosis for pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
Pantothenate Kinase-Associated Neurodegeneration
Functional connectivity of the motor system in dystonia due to PKAN.
Pantothenate Kinase-Associated Neurodegeneration
Gene symbol: PANK2. Disease: Pantothenate kinase associated neurodegeneration (PKAN).
Pantothenate Kinase-Associated Neurodegeneration
Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
17128452, 17128453, 17128454, 17128458, 17128475, 17128476, 17128477, 17128478, 17128479, 17128480, 17128481
Pantothenate Kinase-Associated Neurodegeneration
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
Pantothenate Kinase-Associated Neurodegeneration
Hallervorden-Spatz Syndrome with Seizures.
Pantothenate Kinase-Associated Neurodegeneration
Hallervorden-Spatz syndrome.
Pantothenate Kinase-Associated Neurodegeneration
Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Hereditary causes of disturbed iron homeostasis in the central nervous system.
Pantothenate Kinase-Associated Neurodegeneration
Impaired Coenzyme A metabolism affects histone and tubulin acetylation in Drosophila and human cell models of pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Inborn errors of coenzyme A metabolism and neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Induction of Neuron-Specific Degradation of Coenzyme A Models Pantothenate Kinase-Associated Neurodegeneration by Reducing Motor Coordination in Mice.
Pantothenate Kinase-Associated Neurodegeneration
Influence of the Plant Extract Complex "AdMax" on Global Gene Expression Levels in Cultured Human Fibroblasts.
Pantothenate Kinase-Associated Neurodegeneration
Iron Accumulation in Syndromes of Neurodegeneration with Brain Iron Accumulation 1 and 2 - causative or consequential?
Pantothenate Kinase-Associated Neurodegeneration
Iron toxicity as a potential factor in AMD.
Pantothenate Kinase-Associated Neurodegeneration
Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease.
Pantothenate Kinase-Associated Neurodegeneration
Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Missense PANK2 mutation without "Eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
Pantothenate Kinase-Associated Neurodegeneration
Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients.
Pantothenate Kinase-Associated Neurodegeneration
Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Neuroacanthocytosis: new developments in a neglected group of dementing disorders.
Pantothenate Kinase-Associated Neurodegeneration
Neurodegeneration with brain iron accumulation.
Pantothenate Kinase-Associated Neurodegeneration
Neurodegeneration with brain iron accumulation: A cautionary tale.
Pantothenate Kinase-Associated Neurodegeneration
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.
Pantothenate Kinase-Associated Neurodegeneration
Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel compound heterozygous mutations in the pantothenate kinase 2 gene in a korean patient with atypical pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Pantothenate Kinase-Associated Neurodegeneration
Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel mutation in the PANK2 gene leads to pantothenate kinase-associated neurodegeneration in a Pakistani family.
Pantothenate Kinase-Associated Neurodegeneration
Novel PANK2 gene mutations in korean patient with pantothenate kinase-associated neurodegeneration presenting unilateral dystonic tremor.
Pantothenate Kinase-Associated Neurodegeneration
Novel PANK2 gene mutations in two Chinese siblings with atypical pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel PANK2 mutation discovered among South East Asian children living in Thailand affected with pantothenate kinase associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Novel PANK2 mutation in a Chinese boy with PANK2-associated neurodegeneration: A case report and review of Chinese cases.
Pantothenate Kinase-Associated Neurodegeneration
Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.
Pantothenate Kinase-Associated Neurodegeneration
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Pantothenate Kinase-Associated Neurodegeneration
PANK2 mutation screening recommended to confirm diagnosis of pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
PANK2 p.A170fs?a novel pathogenetic mutation, compound with PANK2 p.R440P, causing pantothenate kinase Associated neurodegeneration in a Chinese family.
Pantothenate Kinase-Associated Neurodegeneration
Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase 2 mutation with eye-of-the-tiger sign on magnetic resonance imaging in three siblings.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase associated neurodegeneration (Hallervorden - Spatz syndrome).
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate Kinase Associated Neurodegeneration in Two Brothers.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration (PKAN) in a child with Down syndrome. A case report and follow-up with MRI.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration in two Chinese children: identification of a novel PANK2 gene mutation.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration in two Taiwanese siblings: identification of a novel PANK2 gene mutation.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate kinase-associated neurodegeneration: novel mutations in the PANK2 gene in an Argentinean young woman.
Pantothenate Kinase-Associated Neurodegeneration
Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.
Pantothenate Kinase-Associated Neurodegeneration
Phenotypes and genotypes of patients with pantothenate kinase-associated neurodegeneration in Asian and Caucasian populations: 2 cases and literature review.
Pantothenate Kinase-Associated Neurodegeneration
Precision medicine in pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Pyruvate dehydrogenase E2 deficiency: A potentially treatable cause of episodic dystonia.
Pantothenate Kinase-Associated Neurodegeneration
Rare causes of hereditary iron overload.
Pantothenate Kinase-Associated Neurodegeneration
Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
Pantothenate Kinase-Associated Neurodegeneration
The "Eye-of-the-Tiger" Sign may be Absent in the Early Stages of Classic Pantothenate Kinase Associated Neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
Pantothenate Kinase-Associated Neurodegeneration
Transcranial sonography in pantothenate kinase-associated neurodegeneration.
Pantothenate Kinase-Associated Neurodegeneration
Turnover rate of coenzyme A in mouse brain and liver.
Pantothenate Kinase-Associated Neurodegeneration
[123I]FP-CIT SPECT findings in two patients with Hallervorden-Spatz disease with homozygous mutation in PANK2 gene.
Pantothenate Kinase-Associated Neurodegeneration
[Clinical manifestations and detection of pantothenate kinase 2 gene mutation in a patient with Hallervorden-Spatz syndrome]
Pantothenate Kinase-Associated Neurodegeneration
[Genetics of hereditary iron overload]
Pantothenate Kinase-Associated Neurodegeneration
[Hemochromatosis: one form of iron-overload diseases].
Pantothenate Kinase-Associated Neurodegeneration
[Studies on PANK2 gene mutations in Chinese patients with Hallervorden-Spatz syndrome]
Paraplegia
Rare causes of dystonia parkinsonism.
Parkinson Disease
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Parkinson Disease
Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease.
Parkinsonian Disorders
A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.
Parkinsonian Disorders
Dramatic Improvement in Juvenile Parkinsonism after Levodopa Treatment in a Patient Negative for the PANK2 Mutation.
Parkinsonian Disorders
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
Parkinsonian Disorders
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Parkinsonian Disorders
Rare causes of dystonia parkinsonism.
Parkinsonian Disorders
Young-onset parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome.
Parkinsonian Disorders
[Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)]
Periodontitis
Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
Propionic Acidemia
Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia.
Protein Deficiency
[Anesthesia considerations for deep-brain stimulation in a patient with type-2 pantothenate kinase deficiency (Hallervorden-Spatz disease)]
Retinal Degeneration
Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia.
Retinal Degeneration
Iron toxicity as a potential factor in AMD.
Retinal Degeneration
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.
Retinal Degeneration
Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model.
Retinal Telangiectasis
Novel mutation in PANK2 associated with retinal telangiectasis.
Retinitis Pigmentosa
Characterization of the human PANK2 promoter.
Retinitis Pigmentosa
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic.
Retinitis Pigmentosa
PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Retinitis Pigmentosa
Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
Seizures
Hallervorden-Spatz Syndrome with Seizures.
Siderosis
Iron toxicity as a potential factor in AMD.
Staphylococcal Infections
Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.
Starvation
p53-dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene.
Tremor
A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.
Tremor
Novel PANK2 gene mutations in korean patient with pantothenate kinase-associated neurodegeneration presenting unilateral dystonic tremor.
Tremor
Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene.
Tuberculosis
Assessment of Mycobacterium tuberculosis Pantothenate kinase vulnerability through target knock down and mechanistically diverse inhibitors.
Tuberculosis
Biochemical and structural studies of mutants indicate concerted movement of the dimer interface and ligand-binding region of Mycobacterium tuberculosis pantothenate kinase.
Tuberculosis
Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis.
Tuberculosis
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of pantothenate kinase from Mycobacterium tuberculosis.
Tuberculosis
Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach.
Tuberculosis
Location and conformation of pantothenate and its derivatives in Mycobacterium tuberculosis pantothenate kinase: insights into enzyme action.
Tuberculosis
M. tuberculosis pantothenate kinase: dual substrate specificity and unusual changes in ligand locations.
Tuberculosis
Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora.
Tuberculosis
Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action.
Tuberculosis
Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
Tuberculosis
Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinase.
Tuberculosis
The first synthesis of podocarflavone A and its analogs and evaluation of their antimycobacterial potential against Mycobacterium tuberculosis with the support of virtual screening.
Ventricular Dysfunction
Cardiac PANK1 Deletion Exacerbates Ventricular Dysfunction During Pressure Overload.
Whooping Cough
Crystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Johnson, M.A.; Kuo, Y.M.; Westaway, S.K.; Parker, S.M.; Ching, K.H.; Gitschier, J.; Hayflick, S.J.
Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration
Ann. N. Y. Acad. Sci.
1012
282-298
2004
Homo sapiens (Q9BZ23), Homo sapiens
brenda
Spry, C.; Chai, C.L.; Kirk, K.; Saliba, K.J.
A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites
Antimicrob. Agents Chemother.
49
4649-4657
2005
Homo sapiens, Plasmodium falciparum
brenda
Zhang, Y.M.; Rock, C.O.; Jackowski, S.
Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration
J. Biol. Chem.
281
107-114
2006
Homo sapiens
brenda
Kotzbauer, P.T.; Truax, A.C.; Trojanowski, J.Q.; Lee, V.M.
Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2
J. Neurosci.
25
689-698
2005
Homo sapiens
brenda
Hartig, M.B.; Hoertnagel, K.; Garavaglia, B.; Zorzi, G.; Kmiec, T.; Klopstock, T.; Rostasy, K.; Svetel, M.; Kostic, V.S.; Schuelke, M.; Botz, E.; Weindl, A.; Novakovic, I.; Nardocci, N.; Prokisch, H.; Meitinger, T.
Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation
Ann. Neurol.
59
248-256
2006
Homo sapiens (Q9BZ23), Homo sapiens
brenda
Leonardi, R.; Rock, C.O.; Jackowski, S.; Zhang, Y.M.
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine
Proc. Natl. Acad. Sci. USA
104
1494-1499
2007
Homo sapiens, Homo sapiens (Q9BZ23)
brenda
Clement, F.; Devos, D.; Moreau, C.; Coubes, P.; Destee, A.; Defebvre, L.
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options
Acta Neurol. Belg.
107
26-31
2007
Homo sapiens
brenda
Isaac, C.; Wright, I.; Bhattacharyya, D.; Baxter, P.; Rowe, J.
Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia
Arch. Dis. Child.
93
239-240
2008
Homo sapiens
brenda
Mikati, M.A.; Yehya, A.; Darwish, H.; Karam, P.; Comair, Y.
Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration
Eur. J. Paediatr. Neurol.
13
61-64
2008
Homo sapiens
brenda
Leonardi, R.; Zhang, Y.M.; Lykidis, A.; Rock, C.O.; Jackowski, S.
Localization and regulation of mouse pantothenate kinase 2
FEBS Lett.
581
4639-4644
2007
Homo sapiens, Mus musculus
brenda
Chan, K.Y.; Lam, C.W.; Lee, L.P.; Tong, S.F.; Yuen, Y.P.
Pantothenate kinase-associated neurodegeneration in two Chinese children: identification of a novel PANK2 gene mutation
Hong Kong Med. J.
14
70-73
2008
Homo sapiens
brenda
Hong, B.S.; Senisterra, G.; Rabeh, W.M.; Vedadi, M.; Leonardi, R.; Zhang, Y.M.; Rock, C.O.; Jackowski, S.; Park, H.W.
Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder
J. Biol. Chem.
282
27984-27993
2007
Homo sapiens (Q8TE04), Homo sapiens (Q9H999), Homo sapiens
brenda
Kazek, B.; Jamroz, E.; Gencik, M.; Jezela Stanek, A.; Marszal, E.; Wojaczynska-Stanek, K.
A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication
J. Child Neurol.
22
1256-1259
2007
Homo sapiens
brenda
Freeman, K.; Gregory, A.; Turner, A.; Blasco, P.; Hogarth, P.; Hayflick, S.
Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration
J. Intellect. Disabil. Res.
51
417-426
2007
Homo sapiens
brenda
Wilfred, B.R.; Wang, W.X.; Nelson, P.T.
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways
Mol. Genet. Metab.
91
209-217
2007
Homo sapiens
brenda
Lyoo, C.H.; Prokisch, H.; Meitinger, T.; Lee, S.Y.; Kim, d.o..H.; Lee, M.S.
Anticholinergic-responsive gait freezing in a patient with pantothenate kinase-associated neurodegeneration
Mov. Disord.
23
283-284
2008
Homo sapiens
brenda
Schneider, S.A.; Walker, R.H.; Bhatia, K.P.
The Huntingtons disease-like syndromes: what to consider in patients with a negative Huntingtons disease gene test
Nat. Clin. Pract. Neurol.
3
517-525
2007
Homo sapiens, Homo sapiens (Q9BZ23)
brenda
McNeill, A.; Birchall, D.; Hayflick, S.J.; Gregory, A.; Schenk, J.F.; Zimmerman, E.A.; Shang, H.; Miyajima, H.; Chinnery, P.F.
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation
Neurology
70
1614-1619
2008
Homo sapiens
brenda
Saleheen, D.; Ali, T.; Aly, Z.; Khealani, B.; Frossard, P.M.
Novel mutation in the PANK2 gene leads to pantothenate kinase-associated neurodegeneration in a Pakistani family
Pediatr. Neurol.
37
296-298
2007
Homo sapiens
brenda
Shields, D.C.; Sharma, N.; Gale, J.T.; Eskandar, E.N.
Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration
Pediatr. Neurol.
37
442-445
2007
Homo sapiens
brenda
Wong, R.W.; Richa, D.C.; Hahn, P.; Green, W.R.; Dunaief, J.L.
Iron toxicity as a potential factor in AMD
Retina (Philadelphia, Pa. )
27
997-1003
2007
Homo sapiens
brenda
Wu, Z.; Li, C.; Lv, S.; Zhou, B.
Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model
Hum. Mol. Genet.
18
3659-3672
2009
Drosophila melanogaster, Homo sapiens (Q9BZ23), Homo sapiens
brenda
Doi, H.; Koyano, S.; Miyatake, S.; Matsumoto, N.; Kameda, T.; Tomita, A.; Miyaji, Y.; Suzuki, Y.; Sawaishi, Y.; Kuroiwa, Y.
Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: Clinical features and (99m)Tc-ECD brain perfusion SPECT findings
J. Neurol. Sci.
290
172-176
2009
Homo sapiens
brenda
Leonardi, R.; Zhang, Y.M.; Yun, M.K.; Zhou, R.; Zeng, F.Y.; Lin, W.; Cui, J.; Chen, T.; Rock, C.O.; White, S.W.; Jackowski, S.
Modulation of pantothenate kinase 3 activity by small molecules that interact with the substrate/allosteric regulatory domain
Chem. Biol.
17
892-902
2010
Homo sapiens, Homo sapiens (Q9H999)
brenda
Subramanian, C.; Yun, M.K.; Yao, J.; Sharma, L.K.; Lee, R.E.; White, S.W.; Jackowski, S.; Rock, C.O.
Allosteric regulation of mammalian pantothenate kinase
J. Biol. Chem.
291
22302-22314
2016
Mus musculus, Mus musculus (Q8K4K6), Mus musculus (Q8R2W9), Homo sapiens (Q8TE04), Homo sapiens (Q9BZ23), Homo sapiens (Q9H999), Homo sapiens
brenda
Yao, J.; Subramanian, C.; Rock, C.O.; Jackowski, S.
Human pantothenate kinase 4 is a pseudo-pantothenate kinase
Protein Sci.
28
1031-1047
2019
Homo sapiens, Homo sapiens (Q9H999)
brenda